LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001127510.3:c.2204C>T
APC
· NP_001120982.1:p.(Ala735Val)
· NM_001127510.3
GRCh37: chr5:112173495 C>T
·
GRCh38: chr5:112837798 C>T
Gene:
APC
Transcript:
NM_001127510.3
Final call
Likely Benign
BS1 strong
BP1 supporting
BP2 supporting
Variant details
Gene
APC
Transcript
NM_001127510.3
Protein
NP_001120982.1:p.(Ala735Val)
gnomAD AF
7.125384460961568e-05 (v4.1)
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Benign: BS1 (strong) is met because the non-cancer gnomAD Popmax FAF exceeds the APC VCEP threshold.
2
Likely Benign: BP1 (supporting) is met because codon 735 lies outside the APC VCEP missense exception at codons 1021-1035.
3
Likely Benign: BP2 (supporting) is met because the variant was observed in trans with pathogenic APC p.Arg332Ter.
Final determination:
Under the APC VCEP Version 2.1 framework, one strong benign criterion satisfies the Likely Benign rule, and at least two supporting benign criteria independently satisfy the two-supporting-evidence rule; no pathogenic rule is met.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: c.2204C>T is a missense SNV producing p.Ala735Val, whereas the VCEP PVS1 rule applies only to defined null-variant classes. |
pvs1_variant_assessment
vcep_apc_specifications_supplementary_material_v2
vcep_fig_1_apc_pvs1_decision_tree_2023_10_20
PMID:23159591
|
| PS1 | N/A | Not applicable: APC VCEP missense PS1 is restricted to residues 1026 and 1028, whereas this variant changes residue 735. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PS2 | Not assessed | Not assessed: one reported case lacks confirmed maternity, paternity, parental phenotype, and a qualifying de novo observation. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:23159591
|
| PS3 | Not assessed | Not assessed: no variant-specific RNA or protein functional assay was available to satisfy the APC VCEP PS3 evidence pathways. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PS4 | Not assessed | Not assessed: the exact variant occurred in 1 of 1591 cases, but no Table 1 phenotype points can be assigned from the available report. |
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:23159591
|
| PM1 | N/A | Not applicable: APC VCEP identifies no established pathogenic missense hotspot or approved critical-domain entry covering residue 735. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM2 | Not met | Not met: non-cancer gnomAD v2.1 exome AF is 0.00594% with allele count 14, exceeding the APC VCEP PM2 threshold of 0.0003%. |
cspec
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| PM3 | N/A | Not applicable: the APC VCEP excludes PM3 because familial adenomatous polyposis has autosomal dominant inheritance. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM4 | N/A | Not applicable: the APC VCEP states PM4 is not used, and this missense substitution causes no protein-length change. |
pvs1_variant_assessment
vcep_apc_specifications_supplementary_material_v2
|
| PM5 | N/A | Not applicable: APC VCEP PM5 is restricted to residues 1026 and 1028, but p.Ala735Val affects residue 735. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PM6 | Not assessed | Not assessed: the single reported occurrence has no documented assumed-de-novo status, parental relationship status, or phenotype-point score. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:23159591
|
| PP1 | Not assessed | Not assessed: no qualifying affected relatives, phenotype points, or segregation meioses are reported for c.2204C>T/p.Ala735Val. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:23159591
|
| PP2 | Not met | Not met: APC missense variants are not a frequent disease mechanism, and most are benign, likely benign, or VUS under the VCEP description. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP3 | Not met | Not met: SpliceAI maximum delta 0.00 predicts no significant splice impact, whereas APC missense PP3 requires splicing evidence revealing a possible effect. |
cspec
vcep_apc_specifications_supplementary_material_v2
spliceai
|
| PP4 | N/A | Not applicable: the APC VCEP states PP4 is captured by PS4 and cannot be used independently. |
vcep_apc_specifications_supplementary_material_v2
|
| PP5 | N/A | Not applicable: the APC VCEP does not use PP5 without the primary evidence underlying an expert opinion. |
vcep_apc_specifications_supplementary_material_v2
|
| BA1 | Not met | Not met: non-cancer gnomAD v2.1 exome Popmax FAF is 0.004594%, below the APC VCEP BA1 threshold of at least 0.1%. |
cspec
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS1 | Met | Met at Strong: non-cancer gnomAD v2.1 exome Popmax FAF is 0.004594%, exceeding the APC VCEP BS1 threshold of at least 0.001%. |
cspec
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS2 | Not met | Not met: non-cancer gnomAD v2.1 exomes report zero homozygotes, and no VCEP-qualified healthy-individual phenotype points are available. |
cspec
vcep_apc_specifications_supplementary_material_v2
gnomad_v2
|
| BS3 | N/A | Not applicable: p.Ala735Val is a missense variant at codon 735, outside the VCEP BS3 protein-assay domain of codons 959-2129. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BS4 | Not assessed | Not assessed: no affected member lacking c.2204C>T/p.Ala735Val has a documented APC phenotype-point score. |
cspec
vcep_apc_specifications_supplementary_material_v2
vcep_table_1_262
PMID:23159591
|
| BP1 | Met | Met, supporting: codon 735 is outside the VCEP BP1 exception at codons 1021–1035 for APC missense variants. |
cspec
vcep_apc_specifications_supplementary_material_v2
PMID:23159591
|
| BP2 | Met | Met at Supporting: c.2204C>T was observed once in trans with pathogenic APC p.Arg332Ter (c.994C>T). |
cspec
PMID:23159591
|
| BP3 | N/A | Not applicable: the APC VCEP states BP3 is not used, and c.2204C>T is a missense SNV rather than an in-frame indel. |
pvs1_variant_assessment
vcep_apc_specifications_supplementary_material_v2
|
| BP4 | N/A | Not applicable: APC BP4 explicitly excludes missense variants, and c.2204C>T produces the missense change p.Ala735Val. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| BP5 | Not met | Not met: the reported trans variant is pathogenic APC p.Arg332Ter, not a qualifying alternate polyposis-gene variant. |
vcep_apc_specifications_supplementary_material_v2
PMID:23159591
|
| BP6 | N/A | Not applicable: the APC VCEP does not use BP6 for unsupported expert reports of benignity. |
vcep_apc_specifications_supplementary_material_v2
|
| BP7 | N/A | Not applicable: BP7 covers only synonymous or intronic variants at or beyond +7/-21, while c.2204C>T is an exonic missense variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.